(Q44266652)

1 December 2017

Stimulant treatment of bulimia nervosa with and without attention-deficit disorder: three case reports (English)

1 reference

1 December 2017

1 reference

1 reference

Eric J Drimmer

1

1 reference

1 December 2017

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

19

1 reference

1 December 2017

76-77

1 reference

1 December 2017

1

1 reference

Suppression of Bulimic Symptoms with Methylamphetamine

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

Methylphenidate treatment for bulimia nervosa associated with a cluster B personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

Aetiopathogenesis and pathophysiology of bulimia nervosa: biological bases and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

The use of citalopram in an integrated approach to the treatment of eating disorders: an open study

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

Reboxetine in the treatment of bulimia nervosa: a report of seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

Sertraline in underweight binge eating/purging-type eating disorders: five case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

Effect of amantadine on weight gain during olanzapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2802%2901045-6

7 January 2021

10.1016/S0899-9007(02)01045-6

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12507648